Works matching IS 20500068 AND DT 2024 AND VI 13 AND IP 12
Results: 6
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cti2.70022
- By:
- Publication type:
- Article
Improving diagnosis in patients with obstetric antiphospholipid syndrome through the evaluation of non‐criteria antibodies.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cti2.70021
- By:
- Publication type:
- Article
From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL‐33.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cti2.70020
- By:
- Publication type:
- Article
Autoantibodies in hospitalised patients with COVID‐19.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cti2.70019
- By:
- Publication type:
- Article
Squamous cell carcinoma is associated with reduced IL34 expression, alterations in the Langerhans cell antigen‐processing‐presentation machinery and poor patient survival.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cti2.70018
- By:
- Publication type:
- Article
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cti2.70016
- By:
- Publication type:
- Article